|
TBCK expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.07670017135808E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.7101000311709E-09 |
| Normal-vs-Stage2 |
7.95279999965537E-07 |
| Normal-vs-Stage3 |
2.07722727907367E-13 |
| Normal-vs-Stage4 |
2.34510189045523E-11 |
| Stage1-vs-Stage2 |
9.933000E-01 |
| Stage1-vs-Stage3 |
5.964200E-03 |
| Stage1-vs-Stage4 |
7.595400E-03 |
| Stage2-vs-Stage3 |
7.467900E-02 |
| Stage2-vs-Stage4 |
6.686000E-02 |
| Stage3-vs-Stage4 |
9.349800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.85199974747741E-10 |
| Normal-vs-AfricanAmerican |
3.67159999999922E-05 |
| Normal-vs-Asian |
4.1553999996502E-07 |
| Caucasian-vs-AfricanAmerican |
9.813600E-01 |
| Caucasian-vs-Asian |
3.333000E-01 |
| AfricanAmerican-vs-Asian |
5.607000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.08555436546021E-12 |
| Normal-vs-Female |
8.93739970919682E-10 |
| Male-vs-Female |
5.019800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.19030000300668E-08 |
| Normal-vs-Age(41-60Yrs) |
1.13808962254325E-12 |
| Normal-vs-Age(61-80Yrs) |
1.28470012406012E-10 |
| Normal-vs-Age(81-100Yrs) |
1.114170E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.410000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.573800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.342400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.099200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.151600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.077200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.30070000001503E-06 |
| Classical-VS-Follicular |
9.553600E-01 |
| Classical-VS-Other |
8.976400E-01 |
| Classical-VS-Normal |
1.01420000175878E-08 |
| Tall-VS-Follicular |
1.583420E-04 |
| Tall-VS-Other |
1.150630E-01 |
| Tall-VS-Normal |
1.37667655053519E-13 |
| Follicular-VS-Other |
8.901600E-01 |
| Follicular-VS-Normal |
6.59800003521838E-09 |
| Other-VS-Normal |
2.074100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.13862302603729E-12 |
| Normal-vs-N1 |
2.83070000772767E-09 |
| N0-vs-N1 |
4.869400E-01 |
|
|
